Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. [electronic resource]
- Journal of neurochemistry Mar 2005
- 1021-32 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0022-3042
10.1111/j.1471-4159.2004.02931.x doi
Adrenergic Uptake Inhibitors--pharmacology Analysis of Variance Animals Catecholamine Plasma Membrane Transport Proteins Cell Death--drug effects Cells, Cultured Chlorides--metabolism Dicumarol--pharmacology Dopamine--metabolism Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors Dose-Response Relationship, Drug Electron Spin Resonance Spectroscopy--methods Embryo, Mammalian Enzyme Inhibitors--pharmacology Ferric Compounds--metabolism Fluorescent Antibody Technique--methods Imipramine--pharmacology Indolequinones--pharmacology Iron--toxicity Iron Isotopes--pharmacology Membrane Glycoproteins--metabolism Membrane Transport Modulators Membrane Transport Proteins--antagonists & inhibitors Microscopy, Confocal--methods Models, Biological Morpholines--pharmacology Nerve Tissue Proteins--metabolism Neurons--drug effects Nomifensine--pharmacology Norepinephrine--pharmacology Norepinephrine Plasma Membrane Transport Proteins Rats Rats, Inbred F344 Rats, Wistar Reboxetine Serotonin Plasma Membrane Transport Proteins Sodium--metabolism Substantia Nigra--cytology Symporters--metabolism Thiobarbituric Acid Reactive Substances--metabolism Tyrosine 3-Monooxygenase--metabolism